Industry & Business
Cosmos Health Outlines AI-Driven Nutraceutical Platform in Shareholder Letter
The Greece-based operator signals U.S. distribution ambitions for its nutraceutical and pharmaceutical portfolio as AI-…
All 514 stories
Industry & Business
IM8 Hits $16.7M Monthly Revenue, Implying $200M Run Rate
The milestone signals accelerating consumer demand for premium, science-backed daily supplement stacks in the direct-to…
Ingredients & Formulation
Koi Peptides Launches Wholesale Program for Biotech R&D Labs
The program is positioned strictly for research use, keeping it outside finished-formulation and dietary supplement cha…
Science & Research
Kyowa Kirin Presents Mogamulizumab Data at 2026 WCCL
Four oral presentations and one poster will feature patient-reported outcomes and real-world utilization data for the b…
Science & Research
Vadadustat Patent Portfolio Expands with Orange Book Listing
The moves extend market exclusivity for the HIF-PHI anemia treatment, with implications for branded finished-formulatio…
Regulatory & Policy
FDA Grants Orphan Drug Status to Low-Sodium Oxybate for Sleep Disorder
The designation hinges on a plausible clinical superiority argument over existing oxybate therapies — a regulatory path…
Ingredients & Formulation
Harrow Re-Launches Cyclosporine Eye Emulsion for Pediatric VKC
The prescription re-entry addresses a documented gap in pediatric ophthalmic allergy care, though the product falls out…
Functional Foods & Beverages
Glucosamine-Chondroitin Complex Targets Senior Dog Joint Health
The pet supplement segment is among the fastest-growing categories in functional nutrition, with joint health leading S…
Condition-Specific Health
Gain Therapeutics CEO to Present at Neuro Summit
The clinical-stage biotech is advancing allosteric small molecule therapies — a mechanism drawing growing interest from…
Industry & Business
GEN Restaurant Group Inks Distribution Deal with UNFI
The partnership signals growing foodservice-to-retail crossover as better-for-you restaurant brands pursue broader omni…
Condition-Specific Health
CONNECTA Therapeutics Advances CTH120 Neuroplasticity Trial
The rare CNS indication sits outside core nutraceutical channels, but neuroplasticity modulation is an emerging mechani…
Ingredients & Formulation
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
Cellectis' experimental allogeneic CAR-T therapy lasme-cel receives FDA fast-track designation for treating patients wi…